Medtronic plc

05/18/2026 | Press release | Distributed by Public on 05/18/2026 14:31

Management Change/Compensation (Form 8-K)

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On May 18, 2026, Medtronic plc ("Medtronic" or the "Company") announced that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, and that Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will be assuming the role of Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026. Mr. Wall will remain an employee of the Company until September 1, 2026, to assist with the transition. Mr. Wall is entitled to and will receive severance payments and benefits consistent with Medtronic's severance practices for executive officers as described in Medtronic's 2025 Proxy Statement filed with the Securities and Exchange Commission on August 25, 2025.
Medtronic plc published this content on May 18, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 18, 2026 at 20:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]